Articles From: Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx to ISS Supports Both Clover Nominees to Replace Hampden Bancorp’s Incumbent Directors


CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Earns $18 Million From GSK for Advancing ISIS-TTR Rx investment picks
AstraZeneca advances ISIS-STAT3 Rx in Clinical Development CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Earns $7.5 Million Milestone Payment From AstraZeneca investment picks
-- Isis Earns $27 Million Milestone Payment --
Sign-up for Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy investment picks
2014/10/10
Phase 3 ENDEAR study in infants with SMA enrolling; on track to initiate Phase 3 study in children with SMA later this year Isis to host a webcast at 11:30 a.m. EDT on Friday, October 10 CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Reports Data From ISIS-SMN Rx Phase 2 Studies in Infants and Children With Spinal Muscular Atrophy investment picks
2014/11/7
-- Conference Call Webcast Friday, November 7, 11:30 a.m. ET at www.isispharm.com CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Reports Financial Results and Highlights for Third Quarter 2014 investment picks
2014/12/7
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin Data published in New England Journal of Medicine and featured at the American Society of Hematology annual meeting Isis to host a webcast at 9:00 a.m. ET on Monday, December 8, 2014 CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery investment picks
2014/11/18
- Webcast scheduled on Monday, December 8 at 9:00 a.m. Eastern Time CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting investment picks
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference investment picks
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals to Present at Upcoming Investor Conferences investment picks
Substantial reductions of up to 86% in triglycerides observed All patients achieved a triglyceride level First study to support the role of apoC-III as a key regulator of triglyceride metabolism utilizing multiple pathways CARLSBAD, Calif.
Sign-up for ISIS-APOCIII Rx Phase 2 Study in Patients With Familial Chylomicronemia Published in the New England Journal of Medicine investment picks
2014/12/13
Associated Press BAGHDAD--Islamic State group militants shot down an Iraqi military helicopter, officials said Saturday, killing the two pilots on board and raising fresh concerns about the extremists' ability to attack aircraft amid ongoing U.S.-led coalition airstrikes.
Sign-up for Islamic State Shoots Down Iraqi Helicopter investment picks
ST. LOUIS , Dec.
Sign-up for Isle Of Capri Casinos, Inc. Announces Fiscal 2015 Second Quarter Results investment picks
ST. LOUIS , Nov.
Sign-up for Isle Of Capri Casinos, Inc. Will Report FY 2015 Second Quarter Results investment picks
2014/12/3
Islet Holdings, Inc. (Pink Sheets:ISHI)(“the Company”) recently announced that the Company would expand its business plan to pursue additional and new medical technologies and products.
Sign-up for Islet Holdings, Inc. Adds New Business Pursuits investment picks
2014/12/3
The U.S. non-manufacturing sector powered up last month although hiring slowed, according to data released Wednesday by the Institute for Supply Management.
Sign-up for ISM Index Rises in November investment picks
2014/11/25
By Sara Toth Stub Special to DOW JONES NEWSWIRES JERUSALEM--Shipping and chemicals conglomerate Israel Corp.
Sign-up for Israel Corp. Swings to Profit investment picks
TEL AVIV, Israel , November 25, 2014 /PRNewswire/ -- ILCO announces shareholders' meeting to be held on December 31st to approve the proposed separation of its holdings, and publishes full transaction report detailing the process and proposed new structure ILCO's new strategic focus following the separation will be on its remaining public holdings, Israel Chemicals (NYSE:ICL, TASE:ICL) and Bazan (TASE:ORL), and it will refrain from investing in new companies.
Sign-up for Israel Corporation Moves Forward With the Proposed Strategic Separation of its Holdings investment picks
2014/11/23
By Sara Toth Stub JERUSALEM -- Israeli food maker Osem Invstments Ltd.
Sign-up for Israel's Osem Reports Slight Profit and Revenue Growth investment picks
Starboard is Extremely Gratified that the Two Leading Independent Proxy Voting Advisory Firms Have Recommended Darden Shareholders Vote for All Twelve of Starboard's World-Class Nominees on Starboard's WHITE Proxy Card ISS Concludes that "Significant Board Change Is Warranted" and Glass Lewis States that the Election of all Twelve of Starboard's Nominees "Is More Likely to Effect Long-Term Improvements and Provide Greater Board Oversight" at Darden ISS States that Starboard's Entire Director Slate "Is Endowed with an Embarrassment of Riches" and Glass Lewis Finds Starboard's Twelve Supremely Qualified Nominees to be "Far More Compelling" and "Significantly Better-Suited" than Darden's Proposed Nominees Corporate Governance Research Firm, Proxy Mosaic, Has Also Now Recommended for All Twelve of Starboard's Nominees for Darden Starboard Urges All Shareholders to Follow the Lead of ISS, Glass Lewis, and Proxy Mosaic and Vote the WHITE Proxy Card to Support the
Sign-up for ISS and Glass Lewis Recommend For All Twelve of Starboard's Nominees For Darden investment picks
Concludes that "Significant Board Change Is Warranted" and Recommends Darden Shareholders Vote to Elect All Twelve of Starboard's Nominees at Upcoming Annual Meeting on Starboard's WHITE Proxy Card States that Starboard Has Assembled a "Compelling Slate with Extensive, Deep, and Relevant Experience" that "Is Endowed with an Embarrassment of Riches" Finds that Starboard Has Provided a "More Thoughtful Solution to Board Continuity" Starboard is Extremely Gratified by the Resounding Show of Support From the Two Leading Independent Proxy Voting Advisory Firms in Recommending for the Election of Starboard's Entire Slate of World-Class Nominees Starboard Urges All Shareholders to Follow the Lead of ISS and Glass Lewis and Vote the WHITE Proxy Card to Support the Election of All Twelve of Starboard's Highly Qualified Nominees NEW YORK , Sept.
Sign-up for ISS Recommends For All Twelve of Starboard's Nominees For Darden investment picks
Clover Partners, the general partner of MHC Mutual Conversion Fund, L.P., is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), an influential and leading proxy advisory firm, has chosen to support both Mr.
Sign-up for ISS Supports Both Clover Nominees to Replace Hampden Bancorp’s Incumbent Directors investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx to ISS Supports Both Clover Nominees to Replace Hampden Bancorp’s Incumbent Directors
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent